Editorial: Leukocytes in tularemia-so many cells, so little time

Journal of Leukocyte Biology

Volumn 93, Issue 5, 2013, Pages 641-643

  Allen, Lee Ann H ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Dendritic cell; Francisella tularensis; IL 12; Macrophage; Neutrophil; Th1

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 23; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; USTEKINUMAB;

BACTERIUM DETECTION; CYTOKINE PRODUCTION; DENDRITIC CELL; EDITORIAL; FRANCISELLA TULARENSIS; INFECTION CONTROL; INFECTION RISK; LEUKOCYTE; MACROPHAGE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TULAREMIA;

ANIMALS; MALE; RECEPTORS, INTERLEUKIN-12; TULAREMIA;

FRANCISELLA TULARENSIS;

EID: 84877038934     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1212661     Document Type: Editorial

References (14)

1. Cowley, S., Elkins, K. (2011) Immunity to Francisella. Front. Microbiol. 2, 26.
2. Crane, D. D., Scott, D. P., Bosio, C. M. (2012) Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS One 7, e33349.
3. Melillo, A. A., Foreman, O., Elkins, K. L. (2013) IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection J. Leukoc. Biol. 93, 677-687.
4. Periasamy, S., Singh, A., Sahay, B., Rahman, T., Feustel, P. J., Pham, G. H., Gosselin, E. J., Sellati, T. J. (2011) Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia. J. Leukoc. Biol. 90, 493-507.
5. Bauler, T. J., Chase, J. C., Bosio, C. M. (2011) IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis. J. Immunol. 187, 1845-1855.
6. Saxinger, L. (2012, November 19) Tularemia, pneumonic-Canada: (Alberta) biologic immunomodulator. ProMED Mail, Archive Number 20121119.1415382, International Society for Infectious Diseases, Brookline, MA, USA, from http://www.promedmail. org/?p=2400:1000.
7. Gandhi, M., Alwawi, E., Gordon, K. B. (2010) Anti-p40 antibodies ustekinumab and briakinumab: blockade of interleukin-12 and interleukin-23 in the treatment of psoriasis. Semin. Cutan. Med. Surg. 29, 48-52.
8. Koskinas, J., Tampaki, M., Doumba, P. P., Rallis, E. (2012) Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in an HBsAg negative anti-HBs positive patient. Br. J. Dermatol. doi: 10.1111/ bjd.12120 [Epub ahead of print].
9. Schmitt, D. M., O'Dee, D. M., Brown, M. J., Horzempa, J., Russo, B. C., Morel, P. A., Nau, G. J. Role of NK cells in host defense against pulmonary type A Francisella tularensis infection. Microbes Infect. (2012) http:// dx.doi.org/10.1016/jmicinf.2012.11.008 [Epub ahead of print].
10. Malik, M., Bakshi, C. S., McCabe, K., Catlett, S. V., Shah, A., Singh, R., Jackson, P. L., Gaggar, A., Metzger, D. W., Melendez, J. A., Blalock, J. E., Sellati, T. J. (2007) Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. J. Immunol. 178, 1013-1020.
11. McCaffrey, R. L., Allen, L-A. H. (2006) Pivotal Advance: Francisella tularensis evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J. Leukoc. Biol. 80, 1224-1230.
12. Schwartz, J. T., Barker, J. H., Kaufman, J., Fayram, D. C., McCracken, J. M., Allen, L-A. H. (2012) Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan. J. Immmunol. 188, 3351-3363.
13. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846-852.
14. Mantovani, A., Cassatella, M. A., Costantini, C., Jaillon, S. (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-531.